Literature DB >> 22491774

Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Joachim Denner1, Ralf R Tönjes.   

Abstract

Xenotransplantation may be a solution to overcome the shortage of organs for the treatment of patients with organ failure, but it may be associated with the transmission of porcine microorganisms and the development of xenozoonoses. Whereas most microorganisms may be eliminated by pathogen-free breeding of the donor animals, porcine endogenous retroviruses (PERVs) cannot be eliminated, since these are integrated into the genomes of all pigs. Human-tropic PERV-A and -B are present in all pigs and are able to infect human cells. Infection of ecotropic PERV-C is limited to pig cells. PERVs may adapt to host cells by varying the number of LTR-binding transcription factor binding sites. Like all retroviruses, they may induce tumors and/or immunodeficiencies. To date, all experimental, preclinical, and clinical xenotransplantations using pig cells, tissues, and organs have not shown transmission of PERV. Highly sensitive and specific methods have been developed to analyze the PERV status of donor pigs and to monitor recipients for PERV infection. Strategies have been developed to prevent PERV transmission, including selection of PERV-C-negative, low-producer pigs, generation of an effective vaccine, selection of effective antiretrovirals, and generation of animals transgenic for a PERV-specific short hairpin RNA inhibiting PERV expression by RNA interference.

Entities:  

Mesh:

Year:  2012        PMID: 22491774      PMCID: PMC3346299          DOI: 10.1128/CMR.05011-11

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  347 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  No in vivo infection of triple immunosuppressed non-human primates after inoculation with high titers of porcine endogenous retroviruses.

Authors:  Volker Specke; Roland Plesker; James Wood; Cheick Coulibaly; Kristen Suling; Clive Patience; Reinhard Kurth; Henk-Jan Schuurman; Joachim Denner
Journal:  Xenotransplantation       Date:  2009 Jan-Feb       Impact factor: 3.907

3.  Identification of a full-length cDNA for an endogenous retrovirus of miniature swine.

Authors:  D E Akiyoshi; M Denaro; H Zhu; J L Greenstein; P Banerjee; J A Fishman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines.

Authors:  Armin Ritzhaupt; Luc J W Van Der Laan; Daniel R Salomon; Carolyn A Wilson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts.

Authors:  E Cantu; K R Balsara; B Li; C Lau; S Gibson; A Wyse; K Baig; J Gaca; G V Gonzalez-Stawinski; T Nichols; W Parker; R D Davis
Journal:  Am J Transplant       Date:  2006-11-15       Impact factor: 8.086

6.  Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases.

Authors:  Eva Dörrschuck; Nicole Fischer; Ignacio G Bravo; Kay-Martin Hanschmann; Heidi Kuiper; Andreas Spötter; Ronny Möller; Klaus Cichutek; Carsten Münk; Ralf R Tönjes
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

7.  Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.

Authors:  Jan-Henning Frühauf; Heike Mertsching; Shibashish Giri; Nils Roman Frühauf; Augustinus Bader
Journal:  Liver Int       Date:  2009-08-14       Impact factor: 5.828

8.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.

Authors:  Joachim Denner; Henk-Jan Schuurman; Clive Patience
Journal:  Xenotransplantation       Date:  2009 Jul-Aug       Impact factor: 3.907

Review 9.  Porcine endogenous retrovirus and other viruses in xenotransplantation.

Authors:  Linda Scobie; Yasuhiro Takeuchi
Journal:  Curr Opin Organ Transplant       Date:  2009-04       Impact factor: 2.640

10.  Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection.

Authors:  Cristina Costa; Lisa Zhao; Willis V Burton; Cristina Rosas; Kenneth R Bondioli; Barry L Williams; Thomas A Hoagland; Agustin P Dalmasso; William L Fodor
Journal:  Xenotransplantation       Date:  2002-01       Impact factor: 3.907

View more
  60 in total

Review 1.  The origin of porcine endogenous retroviruses (PERVs).

Authors:  Joachim Denner
Journal:  Arch Virol       Date:  2021-02-06       Impact factor: 2.574

2.  Multiplatform next-generation sequencing identifies novel RNA molecules and transcript isoforms of the endogenous retrovirus isolated from cultured cells.

Authors:  Norbert Moldován; Attila Szucs; Dóra Tombácz; Zsolt Balázs; Zsolt Csabai; Michael Snyder; Zsolt Boldogkoi
Journal:  FEMS Microbiol Lett       Date:  2018-03-01       Impact factor: 2.742

3.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

Review 4.  Use of genetically-engineered pig donors in islet transplantation.

Authors:  Rita Bottino; Massimo Trucco
Journal:  World J Transplant       Date:  2015-12-24

Review 5.  Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature.

Authors:  David K C Cooper; Vikas Satyananda; Burcin Ekser; Dirk J van der Windt; Hidetaka Hara; Mohamed B Ezzelarab; Henk-Jan Schuurman
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

Review 6.  The role of genetically engineered pigs in xenotransplantation research.

Authors:  David K C Cooper; Burcin Ekser; Jagdeece Ramsoondar; Carol Phelps; David Ayares
Journal:  J Pathol       Date:  2015-10-07       Impact factor: 7.996

Review 7.  Pig Liver Xenotransplantation: A Review of Progress Toward the Clinic.

Authors:  David K C Cooper; Ke-Feng Dou; Kai-Shan Tao; Zhao-Xu Yang; A Joseph Tector; Burcin Ekser
Journal:  Transplantation       Date:  2016-10       Impact factor: 4.939

8.  Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV).

Authors:  Alexander Waechter; Joachim Denner
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

9.  Infection in xenotransplantation: opportunities and challenges.

Authors:  Jay A Fishman
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

Review 10.  Current status of porcine islet xenotransplantation.

Authors:  Taylor M Coe; James F Markmann; Charles G Rickert
Journal:  Curr Opin Organ Transplant       Date:  2020-10       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.